Pol Boudes
2018
In 2018, Pol Boudes earned a total compensation of $1.6M as Chief Medical Officer at Cymabay Therapeutics, a 112% increase compared to previous year.
Compensation breakdown
| Bonus | $170,276 |
|---|---|
| Option Awards | $1,009,738 |
| Salary | $405,418 |
| Other | $4,884 |
| Total | $1,590,316 |
Boudes received $1M in option awards, accounting for 63% of the total pay in 2018.
Boudes also received $170.3K in bonus, $405.4K in salary and $4.9K in other compensation.
Rankings
In 2018, Pol Boudes' compensation ranked 6,882nd out of 14,244 executives tracked by ExecPay. In other words, Boudes earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,882 out of 14,244 | 52nd |
Division Manufacturing | 2,639 out of 5,759 | 54th |
Major group Chemicals And Allied Products | 995 out of 2,122 | 53rd |
Industry group Drugs | 836 out of 1,811 | 54th |
Industry Pharmaceutical Preparations | 652 out of 1,385 | 53rd |
Source: SEC filing on April 26, 2019.
Boudes' colleagues
We found four more compensation records of executives who worked with Pol Boudes at Cymabay Therapeutics in 2018.